Publishing their results in The Lancet medical journal, the scientific team led by Dr Kristin Newby at the Duke Clinical Research Institute of North Carolina, said sibrafiban "showed no additional benefit over aspirin" in preventing cardiac arrest.

BBC: Aspirin 'as good as heart drug'

However, he said that his team was still a long way from moving into human research, as scientific and political obstacles had yet to be overcome.

BBC: NEWS | Health | Mouse cloned to cure Parkinson's